Registered sales of Indian Medicines Pharmaceuticals Corporation Limited India 2020

As of August 2020 in India, Indian Medicines Pharmaceuticals Corporation Limited (IMPCL) registered around 696 million Indian rupees in sales. This figure represents a significant increase over sales registered in all of 2019. As the COVID-19 pandemic reached India, demand of Ayurveda medicinal products increased substantially. The IMPCL is a government enterprise which manufactures Ayurveda products.

截至2020年8月，印度印度药品制药有限公司（Indian Medicines Pharmaceuticals Corporation Limited，简称IMPCL）的销售收入约为6.96亿印度卢比。此数据较2019年全年登记的销售额有显著增长。随着COVID-19疫情抵达印度，对阿育吠陀药品的需求大幅上升。IMPCL是一家政府企业，专门生产阿育吠陀产品。